activity
20182022
most citedProtein Representation Learning by Geometric Structure Pretraining

40 citations · 58 across the 4 of their papers we have counts for

collaborators
Showing 2020Show all

6 papers · 1 filter

cs.LG2020

Optimizing Molecules using Efficient Queries from Property Evaluations

Samuel Hoffman, Vijil Chenthamarakshan, Kahini Wadhawan +2

Machine learning based methods have shown potential for optimizing existing molecules with more desirable properties, a critical step towards accelerating new chemical discovery. H…

q-bio.BM2020

Characterizing the Latent Space of Molecular Deep Generative Models with Persistent Homology Metrics

Yair Schiff, Vijil Chenthamarakshan, Karthikeyan Natesan Ramamurthy +1

Deep generative models are increasingly becoming integral parts of the in silico molecule design pipeline and have dual goals of learning the chemical and structural features that…

q-bio.QM2020★ 4 cited

Explaining Chemical Toxicity using Missing Features

Kar Wai Lim, Bhanushee Sharma, Payel Das +2

Chemical toxicity prediction using machine learning is important in drug development to reduce repeated animal and human testing, thus saving cost and time. It is highly recommende…

cs.CL2020

Learning Implicit Text Generation via Feature Matching

Inkit Padhi, Pierre Dognin, Ke Bai +4

Generative feature matching network (GFMN) is an approach for training implicit generative models for images by performing moment matching on features from pre-trained neural netwo…

cs.LG2020

Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics

Payel Das, Tom Sercu, Kahini Wadhawan +12

De novo therapeutic design is challenged by a vast chemical repertoire and multiple constraints, e.g., high broad-spectrum potency and low toxicity. We propose CLaSS (Controlled La…

cs.LG2020

CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models

Vijil Chenthamarakshan, Payel Das, Samuel C. Hoffman +8

The novel nature of SARS-CoV-2 calls for the development of efficient de novo drug design approaches. In this study, we propose an end-to-end framework, named CogMol (Controlled Ge…